Abstract
In June 2018, the Pharmacy Board of Australia (the Board) hosted a pharmacist prescribing forum to consider the need and opportunities for expanding pharmacist involvement in prescribing.
The forum explored the potential expanded role of pharmacists in prescribing in order to contribute to supporting access to medicines in Australia, which aligns with the objectives of the National Scheme, including 'to enable the continuous development of a flexible, responsive and sustainable health workforce and to enable innovation in the education of, and service delivery by, health practitioners’.
A wide range of stakeholders attended the forum, including hospital and community pharmacists, government health department representatives, professional association delegates, state and territory pharmacy authorities, consumer representatives, education providers, the Australian Pharmacy Council, New Zealand government advisers, pharmacists with firsthand experience as prescribers overseas, Pharmacy Board members and Australian Health Practitioner Regulation Agency (AHPRA) staff.
Following the release of a forum report, the Board is currently preparing a discussion paper to seek the views of the pharmacy profession, other health professionals and the public about the need for and potential models of pharmacist prescribing. The discussion paper will be published on the Board’s website under Current consultations in coming months and will be distributed to stakeholders.
The Board encourages interested stakeholders to continue to work together to further inform future work on pharmacist prescribing.
The forum explored the potential expanded role of pharmacists in prescribing in order to contribute to supporting access to medicines in Australia, which aligns with the objectives of the National Scheme, including 'to enable the continuous development of a flexible, responsive and sustainable health workforce and to enable innovation in the education of, and service delivery by, health practitioners’.
A wide range of stakeholders attended the forum, including hospital and community pharmacists, government health department representatives, professional association delegates, state and territory pharmacy authorities, consumer representatives, education providers, the Australian Pharmacy Council, New Zealand government advisers, pharmacists with firsthand experience as prescribers overseas, Pharmacy Board members and Australian Health Practitioner Regulation Agency (AHPRA) staff.
Following the release of a forum report, the Board is currently preparing a discussion paper to seek the views of the pharmacy profession, other health professionals and the public about the need for and potential models of pharmacist prescribing. The discussion paper will be published on the Board’s website under Current consultations in coming months and will be distributed to stakeholders.
The Board encourages interested stakeholders to continue to work together to further inform future work on pharmacist prescribing.
Original language | English |
---|---|
Place of Publication | Melbourne VIC Australia |
Publisher | Pharmacy Board of Australia |
Number of pages | 64 |
Publication status | Published - 14 Sept 2018 |
Externally published | Yes |